Climb Bio, Inc.
CLYM
$6.94
-$0.18-2.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.17M | 19.93M | 19.60M | 19.17M | 15.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.88M | 56.14M | 52.98M | 47.02M | 27.00M |
| Operating Income | -67.88M | -56.14M | -52.98M | -47.02M | -27.00M |
| Income Before Tax | -59.85M | -50.75M | -46.76M | -92.98M | -73.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.85 | -50.75 | -46.76 | -92.98 | -73.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.85M | -50.75M | -46.76M | -92.98M | -73.90M |
| EBIT | -67.88M | -56.14M | -52.98M | -47.02M | -27.00M |
| EBITDA | -44.79M | -25.52M | -10.66M | -- | -- |
| EPS Basic | -0.89 | -0.76 | -0.70 | -2.38 | -2.13 |
| Normalized Basic EPS | -0.56 | -0.45 | -0.41 | -0.40 | -0.24 |
| EPS Diluted | -0.89 | -0.76 | -0.70 | -2.38 | -2.13 |
| Normalized Diluted EPS | -0.56 | -0.45 | -0.41 | -0.40 | -0.24 |
| Average Basic Shares Outstanding | 270.42M | 267.79M | 266.80M | 229.56M | 189.74M |
| Average Diluted Shares Outstanding | 270.42M | 267.79M | 266.80M | 229.56M | 189.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |